Literature DB >> 11320209

Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit.

T Shiraishi1, T Druck, K Mimori, J Flomenberg, L Berk, H Alder, W Miller, K Huebner, C M Croce.   

Abstract

It has been suggested that delayed DNA replication underlies fragility at common human fragile sites, but specific sequences responsible for expression of these inducible fragile sites have not been identified. One approach to identify such cis-acting sequences within the large nonexonic regions of fragile sites would be to identify conserved functional elements within orthologous fragile sites by interspecies sequence comparison. This study describes a comparison of orthologous fragile regions, the human FRA3B/FHIT and the murine Fra14A2/Fhit locus. We sequenced over 600 kbp of the mouse Fra14A2, covering the region orthologous to the fragile epicenter of FRA3B, and determined the Fhit deletion break points in a mouse kidney cancer cell line (RENCA). The murine Fra14A2 locus, like the human FRA3B, was characterized by a high AT content. Alignment of the two sequences showed that this fragile region was stable in evolution despite its susceptibility to mitotic recombination on inhibition of DNA replication. There were also several unusual highly conserved regions (HCRs). The positions of predicted matrix attachment regions (MARs), possibly related to replication origins, were not conserved. Of known fragile region landmarks, five cancer cell break points, one viral integration site, and one aphidicolin break cluster were located within or near HCRs. Thus, comparison of orthologous fragile regions has identified highly conserved sequences with possible functional roles in maintenance of fragility.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11320209      PMCID: PMC33280          DOI: 10.1073/pnas.091095898

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites.

Authors:  C M Wilke; B K Hall; A Hoge; W Paradee; D I Smith; T W Glover
Journal:  Hum Mol Genet       Date:  1996-02       Impact factor: 6.150

2.  Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site.

Authors:  D Mishmar; A Rahat; S W Scherer; G Nyakatura; B Hinzmann; Y Kohwi; Y Mandel-Gutfroind; J R Lee; B Drescher; D E Sas; H Margalit; M Platzer; A Weiss; L C Tsui; A Rosenthal; B Kerem
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

3.  Novel tumor suppressor locus in human chromosome region 3p14.2.

Authors:  K Jülicher; G Marquitan; N Werner; W Bardenheuer; L Vieten; F Bröcker; H Topal; S Seeber; B Opalka; J Schütte
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

4.  Sequence of the FRA3B common fragile region: implications for the mechanism of FHIT deletion.

Authors:  H Inoue; H Ishii; H Alder; E Snyder; T Druck; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Cancer-specific chromosome alterations in the constitutive fragile region FRA3B.

Authors:  K Mimori; T Druck; H Inoue; H Alder; L Berk; M Mori; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

6.  A conserved sequence block in murine and human T cell receptor (TCR) Jalpha region is a composite element that enhances TCR alpha enhancer activity and binds multiple nuclear factors.

Authors:  C L Kuo; M L Chen; K Wang; C K Chou; B Vernooij; D Seto; B F Koop; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

7.  A comparative mapping study of fragile sites in the human and murine genomes.

Authors:  M Djalali; S Adolph; P Steinbach; H Winking; H Hameister
Journal:  Hum Genet       Date:  1987-10       Impact factor: 4.132

8.  The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.

Authors:  T W Glover; A W Hoge; D E Miller; J E Ascara-Wilke; A N Adam; S L Dagenais; C M Wilke; H A Dierick; D G Beer
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

9.  The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells.

Authors:  Y Pekarsky; T Druck; M G Cotticelli; M Ohta; J Shou; J Mendrola; J C Montgomery; A M Buchberg; L D Siracusa; G Manenti; L Y Fong; T A Dragani; C M Croce; K Huebner
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

10.  Direct cloning and analysis of DNA sequences from a region of the Chinese hamster genome associated with aphidicolin-sensitive fragility.

Authors:  A H Palin; R Critcher; D J Fitzgerald; J N Anderson; C J Farr
Journal:  J Cell Sci       Date:  1998-06       Impact factor: 5.285

View more
  21 in total

1.  Generation and comparative analysis of approximately 3.3 Mb of mouse genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in Williams syndrome.

Authors:  Udaya DeSilva; Laura Elnitski; Jacquelyn R Idol; Johannah L Doyle; Weiniu Gan; James W Thomas; Scott Schwartz; Nicole L Dietrich; Stephen M Beckstrom-Sternberg; Jennifer C McDowell; Robert W Blakesley; Gerard G Bouffard; Pamela J Thomas; Jeffrey W Touchman; Webb Miller; Eric D Green
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

2.  Molecular basis for expression of common and rare fragile sites.

Authors:  Eitan Zlotorynski; Ayelet Rahat; Jennifer Skaug; Neta Ben-Porat; Efrat Ozeri; Ruth Hershberg; Ayala Levi; Stephen W Scherer; Hanah Margalit; Batsheva Kerem
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

3.  Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability.

Authors:  Michal Schwartz; Eitan Zlotorynski; Michal Goldberg; Efrat Ozeri; Ayelet Rahat; Carlos le Sage; Benjamin P C Chen; David J Chen; Reuven Agami; Batsheva Kerem
Journal:  Genes Dev       Date:  2005-11-15       Impact factor: 11.361

4.  Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes.

Authors:  Anne Helmrich; Karen Stout-Weider; Klaus Hermann; Evelin Schrock; Thomas Heiden
Journal:  Genome Res       Date:  2006-09-05       Impact factor: 9.043

Review 5.  Common fragile genes and digestive tract cancers.

Authors:  Tamotsu Kuroki; Yoshitsugu Tajima; Jyunichiro Furui; Takashi Kanematsu
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 6.  Comparative genomics and molecular dynamics of DNA repeats in eukaryotes.

Authors:  Guy-Franck Richard; Alix Kerrest; Bernard Dujon
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 7.  Interplay between genetic and epigenetic factors governs common fragile site instability in cancer.

Authors:  Efrat Ozeri-Galai; Michal Tur-Sinai; Assaf C Bester; Batsheva Kerem
Journal:  Cell Mol Life Sci       Date:  2014-10-09       Impact factor: 9.261

8.  Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation.

Authors:  Takema Kato; Colleen P Franconi; Molly B Sheridan; April M Hacker; Hidehito Inagakai; Thomas W Glover; Martin F Arlt; Harry A Drabkin; Robert M Gemmill; Hiroki Kurahashi; Beverly S Emanuel
Journal:  Cancer Genet       Date:  2014-03-18

9.  A high resolution map of mammalian X chromosome fragile regions assessed by large-scale comparative genomics.

Authors:  Carlos Fernando Prada; Paul Laissue
Journal:  Mamm Genome       Date:  2014-08-03       Impact factor: 2.957

10.  Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic.

Authors:  Ayumi Matsuyama; Takeshi Shiraishi; Francesco Trapasso; Tamotsu Kuroki; Hansjuerg Alder; Masaki Mori; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.